PT-141

most data

Also seen as: Bremelanotide, bremelanotide, Vyleesi

The Dose Guy’s verdict

Sep 1, 2026
3 sources

PT-141 does something the PDE5 inhibitors cannot: it works on wanting, not plumbing. If your libido has gone quiet and the mechanical side is fine, this is the compound that addresses the actual problem, and it has real trial data behind it. The honest catches: nausea hits hard, it is largely redundant if you already run MT-2, and the effect is modest by the numbers. Worth trying if low desire is the bottleneck, not a default stack item.

Would I take it?If you need it, and you're not already on MT-2.

What it is

A synthetic melanocortin peptide that activates MC3 and MC4 receptors in the brain. Where sildenafil and tadalafil work downstream on blood flow, PT-141 works upstream on the wanting itself, the central arousal circuitry that makes you interested in the first place. That is a genuinely different target, and the reason it exists as a separate tool, not just another blood-flow drug.

The melanocortin receptors it hits are the same ones MT-2 lights up, which is why MT-2 users report a libido bump alongside the tan. If you already run MT-2, you are getting most of what PT-141 offers, which makes adding it redundant. For everyone else, PT-141 is the isolated version of that signal: desire without the pigmentation.

What the research shows

FDA-approved for low desire in premenopausal women on the strength of two phase 3 trials, with earlier data in men. The numbers are real but modest:

Across two 24-week trials, bremelanotide improved desire scores by 0.35 points over placebo and reduced desire-related distress by 0.33 points, both with p less than 0.001.Obstet Gynecol 2019 · 2 phase 3 RCTs · n=1267

Nausea hit 40.0% on bremelanotide versus 1.3% on placebo. Flushing in 20.3%, headache in 11.3%. Nausea was the leading reason people stopped.J Womens Health 2022 · integrated safety · n=3500

An independent reanalysis put the number needed to harm for adverse-event discontinuation at 6: for every six people treated, one more than placebo will stop because of side effects.J Sex Res 2021 · phase 3 reanalysis

Realistic protocols

PT-141 is an as-needed compound, not a daily. You pin it subcutaneously at least 45 minutes before you want the effect, and the desire window lasts roughly four to six hours. Do not dose more than once in 24 hours; the nausea stacks with repeated dosing and the blood-pressure bump adds up.

For women, 1.75 mg is the studied dose and the right starting point. For men, who use it off-label, 1 to 2 mg is what the community runs. The early trials tested higher doses, 4 to 6 mg subcutaneously, but the community settled lower to manage the nausea. Start at the low end either way and see how the nausea lands before going higher. Some people find that a smaller dose, around 1 mg, gives the desire boost with less gut misery, and that trade-off is worth exploring.

The redundancy question matters. If MT-2 is already in your rotation, you are hitting the same MC4 receptor and almost certainly getting the libido signal already. Adding PT-141 on top is doubling up on a pathway you have already activated. If you are not running MT-2 and low desire is the specific problem, PT-141 is the targeted tool.

Women1.75 mgSub-q, 45+ min before, the approved dose and the right start.

Men1–2 mgSub-q, same timing, start at 1 mg to gauge the nausea.

Ceiling1 dose/24 hrNausea and blood pressure compound with repeated dosing.

Side effects

Nausea is the headline, and it is not subtle:

commonNausea, often strong. It was the top reason people quit the trials. Usually peaks within an hour of the injection and fades, but for some it ruins the evening it was supposed to improve.

commonFlushing and warmth, the melanocortin tell. Harmless but noticeable.

monitorA transient blood-pressure bump of a few mmHg systolic, peaking within the first hours. Worth knowing if yours already runs high.

monitorFocal hyperpigmentation with repeated daily use. Rare at as-needed dosing, but seen in more than a third of subjects who dosed daily for 16 straight days. Stick to as-needed.